首页> 外文期刊>Vaccine >Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity
【24h】

Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity

机译:表达双突变霍乱毒素A和B亚基的口服MucoRice诱导毒素特异性中和免疫

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Rice-expressed cholera toxin B (CTB) subunit is a cold-chain-free oral vaccine that effectively induces enterotoxin-neutralising immunity. We created another rice-based vaccine, MucoRice, expressing nontoxic double-mutant cholera toxin (dmCT) with CTA and CTB subunits. Western-blot analysis suggested that MucoRice-dmCT had the shape of a multicomponent vaccine. Oral administration of MucoRice-dmCT induced CTB- but not CTA-specific serum IgG and mucosal IgA antibodies, generating protective immunity against cholera toxin without inducing rice-protein-specific antibody responses. The potency of MucoRice-dmCT was equal to that of MucoRice-CTB vaccine. MucoRice has the potential to be used as a safe multicomponent vaccine expression system. (C) 2009 Elsevier Ltd. All rights reserved.
机译:水稻表达的霍乱毒素B(CTB)亚基是一种无冷链口服疫苗,可有效诱导肠毒素中和免疫。我们创建了另一种基于水稻的疫苗MucoRice,该疫苗表达具有CTA和CTB亚基的无毒双突变霍乱毒素(dmCT)。 Western印迹分析表明,MucoRice-dmCT具有多组分疫苗的形状。口服MucoRice-dmCT可以诱导CTB特异性,但不能诱导CTA特异性血清IgG和粘膜IgA抗体,从而产生针对霍乱毒素的保护性免疫而不诱导大米蛋白特异性抗体反应。 MucoRice-dmCT的效力与MucoRice-CTB疫苗的效力相同。 MucoRice有潜力用作安全的多组分疫苗表达系统。 (C)2009 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号